Idexx Laboratories (IDXX) Gross Margin (2009 - 2026)

Idexx Laboratories' Gross Margin history runs 18 years deep, the most recent figure standing at 63.35% for Q1 2026.

• In Q1 2026, Gross Margin rose 92.0% year-over-year to 63.35%; the TTM figure through Mar 2026 stood at 62.05% (up 78.0% YoY), while the FY2025 annual figure was 61.8%, up 76.0% from the prior year.
• Gross Margin for Q1 2026 stood at 63.35%, up from 60.35% in the prior quarter.
• The five-year high for Gross Margin was 63.35% in Q1 2026, with the low at 58.36% in Q4 2023.
• The 5-year median for Gross Margin is 60.35% (2025), against an average of 60.71%.
• Peak annual rise in Gross Margin reached 184 bps in 2022, while the deepest fall reached 91 bps in 2022.
• Idexx Laboratories' Gross Margin stood at 58.53% in 2022, then declined by 0 bps to 58.36% in 2023, then advanced by 2 bps to 59.8% in 2024, then rose by 1 bps to 60.35% in 2025, then grew by 5 bps to 63.35% in 2026.
• Business Quant data shows IDXX's Gross Margin at 63.35% in Q1 2026, 60.35% in Q4 2025, and 61.83% in Q3 2025.